Author Archives: Denise Bell

Foldax Named Finalist in the Fierce Innovation Awards

By Denise Bell | Published October 2, 2020

Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020, a peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma. The company was selected as a finalist for its innovative TriaTM heart valve. The Tria valve reimagines the heart valve by incorporating a new, […]

Posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

Trump Administration Issues Final Drug Importation Rule

By Denise Bell | Published October 2, 2020

On September 24, the Trump Administration released a final rule to allow the importation of prescription drugs from Canada. The final rule follows a notice of proposed rule making last December, in which HHS outlined two potential pathways for importation. The first called the Section 804 Importation Program, is established under the final rule, while […]

Posted in Policy News | Leave a comment

Alucent Biomedical Announces $35 Million Series B Financing

By Denise Bell | Published October 2, 2020

Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is treated, yesterday announced the close of a $35 million Series B financing round. The funding will support two clinical trials to evaluate Alucent’s novel treatment for peripheral artery disease (PAD) of the lower extremities. PAD is a […]

Posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration

By Denise Bell | Published September 25, 2020

IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung Test™ for lung cancer has been formally accepted for submission to China’s National Medical Products Administration (NMPA), formerly known as the Chinese Food and Drug Administration (CFDA). Mr. Jared Bauer, IONIQ Sciences CEO, stated, “We are excited […]

Posted in BioUtah News, Utah's Life Sciences Companies | Leave a comment

J&J Enters Phase 3 Trial for COVID-19 Vaccine

By Denise Bell | Published September 25, 2020

BioUtah member Johnson & Johnson (J&J) announced that they’ve started the global phase 3 trial of Janssen’s single-dose vaccine candidate, following phase 1/2 studies that demonstrated safety and immunogenicity. “As COVID-19 continues to impact the daily lives of people around the world, our goal remains the same – leveraging the global reach and scientific innovation […]

Posted in BioUtah COVID-19 Analysis, Federal News, Industry News | Leave a comment

SDP Oncology Announces New Data from Phase 1 Solid Tumor Study

By Denise Bell | Published September 25, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase 1 study evaluating dubermatinib (TP-0903) in patients with advanced solid tumors. “These preliminary data presented at ESMO 2020 are encouraging as we learn more about how dubermatinib may inhibit the AXL kinase protein and sensitize cancer cells […]

Posted in BioUtah News, Utah's Life Sciences Companies | Leave a comment

President Trump Signs Executive Order on Healthcare, Pre-existing Conditions

By Denise Bell | Published September 25, 2020

During a campaign event yesterday in Charlotte, North Carolina, President Trump signed an executive order on a range of health issues, including protecting people with pre-existing medical conditions, lowering prescription drug costs, increasing consumer choice, and providing greater transparency. The order also directs HHS Secretary Alex Azar to work with Congress to pass legislation to […]

Posted in Federal News, Policy News | Leave a comment

RenalytixAI Receives California Commercial Lab Certification

By Denise Bell | Published September 25, 2020

RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from the California Department of Health for its clinical laboratory in Salt Lake City, Utah. This means that KidneyIntelX™ may now be used to report risk assessment of progressive decline in kidney function for patients in California with […]

Posted in BioUtah News, Utah's Life Sciences Companies | Leave a comment

Utah COVID-19 Grant Programs Update

By Denise Bell | Published September 18, 2020

BioUtah is pleased to provide the life sciences community with a current summary of state COVID-19 initiatives and grant programs managed by the Governor’s Office of Economic Development. Visit business.utah.gov/coronavirus to learn more. Coronavirus Prevention Messaging Grants Grants of up to $50,000, $75,000 or $250,000 for social media, targeted audience and mass media campaigns, respectively, […]

Posted in Policy News | Leave a comment

Trump Administration Releases COVID-19 Vaccine Distribution Strategy

By Denise Bell | Published September 18, 2020

The Administration on Wednesday released a detailed plan for the distribution of free COVID-19 vaccines beginning next year. The plan would prioritze vaccines for healthcare workers, essential employees, and high-risk indiividuals. From there, distribution would be expanded to the broader population. The plan includes two documents: documents: A strategic distribution overview along with an interim […]

Posted in COVID-19 Updates, Federal News, Policy News | Leave a comment

Fulgent Genetics Lands Utah COVID-19 Testing Contract

By Denise Bell | Published September 18, 2020

TestUtah has some new twists. Following the expiration of certain state contracts September 1, the Utah Department of Public Health has changed direction and contracted with a Los Angeles laboratory, Fulgent Genetics, to process COVID-19 testing for Utahns under the state’s coronavirus testing initiative. The test, which has received EUA from the FDA, will be […]

Posted in BioUtah COVID-19 Analysis, COVID-19 Updates, State News | Leave a comment

The Point Kick Off

By Denise Bell | Published September 18, 2020

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]

Posted in BioUtah News, Industry News, State News, Utah's Life Sciences Companies | Leave a comment

A Special Thanks To Our Elite Members